Cost-Effectiveness of Pembrolizumab for Treating Previously Untreated Metastatic Melanoma Patients in France
Abstract
Authors
C Godard J Wang A Gauthier L Levy-Bachelot L Annemans
C Godard J Wang A Gauthier L Levy-Bachelot L Annemans
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now